Turtle Creek Asset Management continues to build its position in the door and window manufacturer JELD-WEN Holding $JELD.
Friday’s Form 4 filing is its fourth filing in just two weeks and reveals an additional $16.5 million of share purchases.
Expert technical analysis of financial markets by JC Parets
by David
Turtle Creek Asset Management continues to build its position in the door and window manufacturer JELD-WEN Holding $JELD.
Friday’s Form 4 filing is its fourth filing in just two weeks and reveals an additional $16.5 million of share purchases.
by JC
We are almost done with the first quarter of the calendar year and the last quarter of our financial year. There are certain sectors that are peeping out from beneath the surface and hence attracting attention. Is this a theme we may see play out in the quarter going forward? Most likely. Most sectors have remained sideways or subdued in their move and they are finally picking a side!
Today we are here to discuss one such sector and some interesting setups that one could take advantage of.
Let’s see what’s on the roster sheet today.
From the desk of Steve Strazza @Sstrazza
Our Hall of Famers list is composed of the 150 largest US-based stocks.
These stocks range from the mega-cap growth behemoths like Apple and Microsoft – with market caps in excess of $2T – to some of the new-age large-cap disruptors such as Moderna, Square, and Snap.
It has all the big names and more.
It doesn’t include ADRs or any stock not domiciled in the US. But don’t worry; we developed a separate universe for that which you can check out here.
The Hall of Famers is simple.
We take our list of 150 names and then apply our technical filters so the strongest stocks with the most momentum rise to the top.
Let’s dive right in and check out what these big boys are up to.
by David
From the desk of Steve Strazza @Sstrazza
The biggest theme on our Hot List and Inside Scoop tables has been the strength from commodity stocks.
Since we launched the column, we’ve discussed the strength from energy stocks like Occidental Petroleum $OXY, agricultural stocks like Corteva $CTVA, and industrial metal names such as Freeport-McMoRan $FCX.
These names have all recently broken out and continue to show leadership. When the same theme continues to work, we want to continue to bet on it.
And that’s exactly what we’re doing with today’s setup.
by David
Revolution Medicines $RVMD director Thilo Schroeder is back on our list for the third time in just two weeks with another Form 4 filing.
Following last week’s $3.4 million buy, he revealed an additional $5.5 million purchase in his latest filing.
by JC
The question keeps coming up.
As it should.
“JC, do you think this bounce in Growth has legs?”
And the answer is that yes, I think it could. There are some nice trades in these beat up growth areas that have set up very nicely.
We discussed a few of these once again on Monday night.
But I believe this one really depends on your time horizon.
Can Growth outperform for a bit? Sure.
But do I think it can do that throughout the rest of the year?
No I don’t.
Here’s the Large-cap Growth vs Value in black, as well as the Small-cap Growth vs Value in Blue: [Read more…]
by David
There’s a handful of large Form 4 purchases on today’s list.
Robert Gervis, director of Aspen Aerogels $ASPN, purchased $4.5 million of stock.
by JC
We debuted a new scan recently- The Outperformers.
The Outperformers is our newest scan that pinpoints the very best stocks in the market. It’s the fastest, easiest way to find quality names that are primed for major moves.